ERBB2 and breast carcinoma: For example, CARs targeting HER2/IL13Ra2 and HER2/MUC1 were used for glioblastoma and breast cancer treatment, respectively.[46] These dual‐targeting CAR‐T therapy exerted superior anti‐tumor effect compared to single‐targeting CAR‐T cells.